PortfoliosLab logoPortfoliosLab logo
Absci Corporation (ABSI)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US00091E1091
CUSIP
00091E109
IPO Date
Jul 22, 2021

Highlights

Market Cap
$451.83M
Enterprise Value
$439.79M
EPS (TTM)
-$0.82
Total Revenue (TTM)
$2.80M
Gross Profit (TTM)
-$36.85M
EBITDA (TTM)
-$112.98M
Year Range
$2.01 - $5.23
Target Price
$6.16
ROA (TTM)
-53.25%
ROE (TTM)
-60.80%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Absci Corporation

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Absci Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Absci Corporation (ABSI) has returned -14.04% so far this year and 19.52% over the past 12 months.


Absci Corporation

1D
8.70%
1M
9.49%
YTD
-14.04%
6M
-1.32%
1Y
19.52%
3Y*
19.68%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jul 22, 2021, ABSI's average daily return is +0.01%, while the average monthly return is +0.54%. At this rate, your investment would double in approximately 10.7 years.

Historically, 39% of months were positive and 61% were negative. The best month was Dec 2023 with a return of +151.5%, while the worst month was May 2022 at -38.2%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 5 months.

On a daily basis, ABSI closed higher 49% of trading days. The best single day was May 22, 2023 with a return of +30.2%, while the worst single day was Nov 13, 2025 at -22.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-14.33%-8.36%9.49%-14.04%
202541.60%3.77%-34.81%22.31%-13.68%-3.02%10.12%-15.55%27.20%40.79%-25.93%10.09%33.21%
2024-5.71%30.30%10.08%-16.55%-11.18%-26.84%42.86%-0.00%-13.18%0.52%-20.57%-14.10%-37.62%
202349.52%-32.48%-17.45%-24.57%43.94%-20.00%44.74%-18.64%-26.26%-1.52%28.46%151.50%100.00%
2022-17.93%39.23%-10.03%-29.89%-38.24%-9.04%-0.90%2.43%-7.12%0.96%-20.89%-16.00%-74.39%
202131.91%-34.06%-38.07%26.14%-28.08%-22.27%-62.02%

Benchmark Metrics

Absci Corporation has an annualized alpha of -16.95%, beta of 2.19, and R² of 0.15 versus S&P 500 Index. Calculated based on daily prices since July 23, 2021.

  • This stock participated in 205.00% of S&P 500 Index downside but only 51.01% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.15 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-16.95%
Beta
2.19
0.15
Upside Capture
51.01%
Downside Capture
205.00%

Return for Risk

Risk / Return Rank

ABSI ranks 50 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


ABSI Risk / Return Rank: 5050
Overall Rank
ABSI Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
ABSI Sortino Ratio Rank: 5555
Sortino Ratio Rank
ABSI Omega Ratio Rank: 5252
Omega Ratio Rank
ABSI Calmar Ratio Rank: 4646
Calmar Ratio Rank
ABSI Martin Ratio Rank: 4646
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Absci Corporation (ABSI) and compare them to a chosen benchmark (S&P 500 Index).


ABSIBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.22

0.90

-0.68

Sortino ratio

Return per unit of downside risk

1.01

1.39

-0.38

Omega ratio

Gain probability vs. loss probability

1.12

1.21

-0.09

Calmar ratio

Return relative to maximum drawdown

0.21

1.40

-1.19

Martin ratio

Return relative to average drawdown

0.39

6.61

-6.21

Explore ABSI risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Absci Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Absci Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Absci Corporation was 96.20%, occurring on Oct 26, 2023. The portfolio has not yet recovered.

The current Absci Corporation drawdown is 90.10%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.2%Aug 4, 2021562Oct 26, 2023
-1.23%Jul 27, 20211Jul 27, 20211Jul 28, 20212
-0.21%Jul 30, 20211Jul 30, 20211Aug 2, 20212

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Absci Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Absci Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ABSI relative to other companies in the Biotechnology industry. Currently, ABSI has a P/S ratio of 150.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ABSI in comparison with other companies in the Biotechnology industry. Currently, ABSI has a P/B value of 2.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items